XBIO
Xenetic BiosciencesCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
8
U.S. public peers
Grade Position
In line
vs peer average
XBIO vs peer average
66/100
XBIO vs. peer average (C vs. D)
Grade spread
A 1 · B 1 · D 1 · F 5
Graded peers loaded
Coverage
8 graded
100% of tracked
Peer overview
ACXP is the first available peer comparator.
Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $7.74M
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
XBIO
Xenetic Biosciences
ACXP
Acurx
Grade
C
F
Momentum
63
31
Value
41
41
Sentiment
-
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Mixed
Defensive
Grade position vs ACXP
XBIO / ACXP
Grade Position
In line
XBIO vs. peer average (C vs. D)
66/100
Momentum
63
XBIOValue
41
XBIOSentiment
-
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs XBIO
ACXP is the first peer returned for this comparison set.

